These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23708661)

  • 1. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
    Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
    Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.
    Yang Y; Liao Q; Wei F; Li X; Zhang W; Fan S; Shi L; Li X; Gong Z; Ma J; Zhou M; Xiang J; Peng S; Xiang B; Deng H; Yang Y; Li Y; Xiong W; Zeng Z; Li G
    PLoS One; 2013; 8(5):e62869. PubMed ID: 23650533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
    Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
    Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation.
    Liu DB; Hu GY; Long GX; Qiu H; Mei Q; Hu GQ
    Acta Pharmacol Sin; 2012 May; 33(5):682-90. PubMed ID: 22504904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells.
    Zhang G; Tsang CM; Deng W; Yip YL; Lui VW; Wong SC; Cheung AL; Hau PM; Zeng M; Lung ML; Chen H; Lo KW; Takada K; Tsao SW
    PLoS One; 2013; 8(5):e62284. PubMed ID: 23658720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts.
    Tsang CM; Cheung YC; Lui VW; Yip YL; Zhang G; Lin VW; Cheung KC; Feng Y; Tsao SW
    BMC Cancer; 2013 Dec; 13():619. PubMed ID: 24380387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma.
    Zhou X; Xiao X; Huang T; Du C; Wang S; Mo Y; Ma N; Murata M; Li B; Wen W; Huang G; Zeng X; Zhang Z
    Oncotarget; 2016 Mar; 7(13):16433-44. PubMed ID: 26918942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
    Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
    Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma.
    Wang H; Zhou Y; Oyang L; Han Y; Xia L; Lin J; Tang Y; Su M; Tan S; Tian Y; Chen X; Luo X; Liang J; Rao S; Wang Y; Xiong W; Zeng Z; Wang H; Li G; Liao Q
    Oncogene; 2019 Jun; 38(25):5062-5075. PubMed ID: 30886235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
    Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
    Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.
    Xu M; Cheung CC; Chow C; Lun SW; Cheung ST; Lo KW
    PLoS One; 2016; 11(6):e0156833. PubMed ID: 27258148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.
    Ou H; Li Y; Kang M
    PLoS One; 2014; 9(11):e109929. PubMed ID: 25365510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
    Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
    BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis.
    Oyang L; Ouyang L; Yang L; Lin J; Xia L; Tan S; Wu N; Han Y; Yang Y; Li J; Chen X; Tang Y; Su M; Luo X; Li J; Xiong W; Zeng Z; Liao Q; Zhou Y
    Cancer Sci; 2023 Mar; 114(3):870-884. PubMed ID: 36382614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling.
    Zhang X; Yang J; Bian Z; Shi D; Cao Z
    Biomed Pharmacother; 2019 May; 113():108713. PubMed ID: 30849642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
    Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
    Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
    Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH
    Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV Rta-induced IL-6 Promotes Migration of Bystander Tumor Cells Through IL-6R/JAK/STAT3 Pathway
    Tung KL; Wu YT; Liu C; Lin SC; Wu CH; Wu SY; Chang Y; Lan YY
    Anticancer Res; 2020 Jun; 40(6):3255-3264. PubMed ID: 32487620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.
    Jiang L; Wang P; Chen L; Chen H
    Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.
    Wei F; Wu Y; Tang L; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
    Br J Cancer; 2018 Jan; 118(2):233-247. PubMed ID: 29123267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.